secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001493152-23-006270
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals CFO Robert Chen resigns; search underway for replacement
------------------------------------------------------------------------------

- CFO Robert Chen notified intent to resign on February 25, 2023.
- Chen also served as Treasurer and Secretary; all roles vacated.
- Company has commenced a search for a successor; no interim named.
- Nasrat Hakim remains President and CEO during the transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223006270/0001493152-23-006270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315223006270/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-006270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer